Intriguingly, chordoma sometimes occurs in patients with tuberous sclerosis complex (44–46), which is characterized by loss of the mTOR negative regulators TSC1/2, further hinting at a role for the PI3K/mTOR pathway in chordoma pathogenesis. This evidence concerns the gene MTOR and chordoma.